Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis

Background. Peroxisome proliferator-activated receptor-α (PPAR-α) is closely associated with the development of cardiac hypertrophy. Previous studies have indicated that bezafibrate (BZA), a PPAR-α agonist, could attenuate insulin resistance and obesity. This study was designed to determine whether...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PPAR Res
Hauptverfasser: Xu, Si-Chi, Ma, Zhen-Guo, Wei, Wen-Ying, Yuan, Yu-Pei, Tang, Qi-Zhu
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi Publishing Corporation 2017
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5239981/
https://ncbi.nlm.nih.gov/pubmed/28127304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5789714
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge